Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.

Assimakopoulos, Stelios F; Seintis, Fotios; Marangos, Markos

Assimakopoulos, Stelios F; Seintis, Fotios; Marangos, Markos.

Assimakopoulos SF; Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Patras, Greece. Electronic address: sassim@upatras.gr.
Seintis F; Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Patras, Greece.
Marangos M; Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Patras, Greece.

Med Hypotheses ; 143: 109926, 2020 10.

Article in English | MEDLINE | ID: covidwho-506787

Subject(s)

Coronavirus Infections/complications; Coronavirus Infections/drug therapy; Pentoxifylline/administration & dosage; Pneumonia, Viral/complications; Pneumonia, Viral/drug therapy; Antibodies, Monoclonal, Humanized/administration & dosage; Betacoronavirus; Blood Coagulation Disorders/drug therapy; COVID-19; Heart Injuries/complications; Humans; Inflammation/drug therapy; Interleukin 1 Receptor Antagonist Protein/administration & dosage; Models, Theoretical; Pandemics; Respiratory Distress Syndrome/complications; Risk; SARS-CoV-2; Surface-Active Agents; Thrombosis/drug therapy; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pentoxifylline / Pneumonia, Viral / Coronavirus Infections Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google